USFDA concludes audit at Radiopharmaceutical manufacturing facility of Jubilant Pharmova’s arm

25 Apr 2024 Evaluate

United States Food and Drug Administration (USFDA) has concluded its audit at Jubilant Pharmova’s step down subsidiary -- Jubilant Draximage Inc’s Radiopharmaceutical manufacturing facility located at Montreal, Canada on April, 23, 2024. The USFDA has issued 5 observations pursuant to the completion of audit. The company will submit an action plan on the observations.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

716.20 0.00 (0.00%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.